Re: Cost of Dilution/Public Offering v Private Placement
|
4
|
Resverlogix Corp.
|
Oct 08, 2020 03:36PM
|
Re: Constellation Pharma
|
3
|
Resverlogix Corp.
|
Jun 29, 2020 02:44PM
|
Re: Compensation
|
2
|
Resverlogix Corp.
|
May 21, 2022 01:34PM
|
Re: Closing Price
|
1
|
Resverlogix Corp.
|
Feb 03, 2020 08:59PM
|
Re: CityNews cover
|
3
|
Resverlogix Corp.
|
Jan 31, 2022 02:22PM
|
Re: Cayman Chemical 1180 East Ellsworth Road Ann Arbor, Michigan 48108 USA
|
1
|
Resverlogix Corp.
|
Jan 16, 2017 09:05PM
|
Re: By the time….
|
8
|
Resverlogix Corp.
|
Mar 03, 2022 11:57PM
|
Re: BTD
|
1
|
Resverlogix Corp.
|
Apr 25, 2022 09:26PM
|
Re: Brilinta-AZ
|
6
|
Resverlogix Corp.
|
Apr 19, 2018 10:55PM
|
Re: Brilinta-AZ
|
3
|
Resverlogix Corp.
|
Apr 20, 2018 09:55AM
|
Re: Breakthrough Designation
|
1
|
Resverlogix Corp.
|
May 28, 2020 05:14PM
|
Re: BOM 2 Trial
|
1
|
Resverlogix Corp.
|
Jun 11, 2020 10:54AM
|
Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
5
|
Resverlogix Corp.
|
Apr 20, 2021 10:45PM
|
Re: Apabetalone MOA diagram
|
3
|
Resverlogix Corp.
|
Sep 28, 2019 11:46AM
|
Re: Apabetalone MOA diagram
|
2
|
Resverlogix Corp.
|
Sep 29, 2019 04:07PM
|
Re: Anyone signed up for ESC 2021?
|
1
|
Resverlogix Corp.
|
Aug 10, 2021 11:41PM
|
Re: Anyone signed up for ESC 2021?
|
|
Resverlogix Corp.
|
Aug 09, 2021 10:36AM
|
Re: Antiviral
|
2
|
Resverlogix Corp.
|
Apr 30, 2021 04:45PM
|
Re: Another reason
|
7
|
Resverlogix Corp.
|
Jan 11, 2022 01:09PM
|
Re: Another quarter and not a peep
|
1
|
Resverlogix Corp.
|
Jan 13, 2023 01:22PM
|